Ileal Absorption of Bile Acids in Patients with Chronic Cholestasis: SeHCAT Test Results and Effect of Ursodeoxycholic Acid (UDCA)

Digestive Diseases and Sciences

Volumn 41, Issue 12, 1996, Pages 2417-2422

  Chazouillères, Olivier ^a   Marteau, Philippe ^b   Haniche, Mostefa ^b   Jian, Raymond ^b   Poupon, Raoul ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

Bile acid absorption; Homocholic acid taurine; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

BILE ACID; TAUROSELCHOLIC ACID SE 75; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILIARY CIRRHOSIS; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; ILEUM; INTESTINE ABSORPTION; MALE; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0030482271     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02100137     Document Type: Article

References (37)

1. Hofmann AF: Chemistry and enterohepatic circulation of bile acids. Hepatology 4:4S-14S, 1984
2. Marcus SN, Schteingart CD, Marquez ML, Hofmann AF, Xia Y, Steinbach J, Ton-Nu HT, Lillienau J, Angellotti MA, Schmassmann: Active absorption of conjugated bile acids in vivo. Gastroenterology 100:212-221, 1991
3. Aldini R, Roda A, Lenzi PL, Ussia G, Vaccari MC, Mazzella G: Bile acid active and passive ileal transport in the rabbit: Effect of luminal stirring. Eur J Clin Invest 22:744-750, 1992
4. Wong MH, Oelkers P, Craddock AL, Dawson PA: Expression cloning and characterization of the hamster ileal sodium-dependant bile acid transporter. J Biol Chem 269:1340-1347, 1994
5. Lillienau J, Crombie DL, Munoz J, Longmire-Cook SJ, Hagey LR, Hofmann AF: Negative feedback regulation of the ileal bile acid transport system in rodents. Gastroenterology 104:38-46, 1993
6. Higgins JV, Paul JM, Dumaswala R, Heubi JE: Downregulation of taurocholate transport by ileal BBM and liver BLM in biliary-diverted rats. Am J Physiol 267:G501-507, 1994
7. Dumaswala R, Berkowitz D, Heubi JE: Adaptive response of enterohepatic circulation of bile salts to extrahepatic cholestasis. Hepatology 23:623-629, 1996
8. Higgins JV, Dumaswala JM, Heubi JE: Up-regulation of taurocholate transport by ileal brush border membrane in bile salt fed rats. Gastroenterology 106:A29, 1994
9. Palmer RH: Bile acids, liver injury, and liver disease. Arch Intern Med 130:606-617, 1972
10. Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group: Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 12:1342-1347, 1994
11. Lindor KD, Dickson RE, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lesage G, Rossi SS, Hofmann AF: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284-1290, 1994
12. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR: The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19:1149-1156, 1994
13. Chazouilleres O, Poupon R, Capron JP, Metman EH, Dhumeaux D, Amouretti M, Couzigou P, Labayle D, Trinchet JC: Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 11:120-123, 1990
14. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 16:707-714, 1992
15. Marteau P, Chazouilleres O, Myara A, Jian R, Rambaud JC, Poupon R: Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology 12:1206-1208, 1990
16. Eusufzai S, Ericcson S, Cederlund T, Einarsson K, Angelin B: Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Gut 32:1044-1048, 1991
17. 75 SeHCAT fractional turnover rate in primary biliary cirrhosis: Effect of ursodeoxycholic acid treatment. Eur J Gastroenterol Hepatol 5:1037-1041, 1993
18. Merrick MV, Eastwood MA, Anderson JR, Ross HMcL: Enterohepatic circulation in man of a gamma-emitting bile acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT). J Nucl Med 23:126-130, 1982
19. 14C] taurocholate. Gastroenterology 95:164-169, 1988
20. Nyhlin H, Merrick MV, Eastwood MA, Brydon WG: Evaluation of ileal function using 23-selena-25-homotaurocholate, a gamma-labeled conjugated bile acid: Initial clinical assessment. Gastroenterology 84:63-68, 1983
21. Sciarretta G, Vicini G, Fagioli G, Verri A, Ginevra A, Malaguti P: Use of 23-selena-25-homocholytaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology 91:1-9, 1986
22. Sciarretta G, Fagioli G, Furno A, Vicini G, Ceccheti L, Grigolo B, Verri A, Malaguti P: 75 SeHCAT test in the detection of bile acid malabsorption in functional diarrhea and its correlation with small bowell transit. Gut 28:970-975, 1987
23. Ferraris R, Jazrawi R, Bridges C, Northfield TC: Use of a gamma labelled bile acid (75-SeHCAT) as a test of ileal function. Methods of improving accuracy. Gastroenterology 90:1129-1136, 1986
24. Labbe D, Gerhardt MF, Myara A, Vercambre C, Trivin F: High-performance liquid chromatographic determination of tauro and glycoconjugated bile acids in human serum. J Chromatogr 490:275-284, 1989
25. Hofmann AF, Bolder U: Detection of bile acid malabsorption by the SeHCAT test. Principles, problems, and clinical utility. Gastroenterol Clin Biol 18:847-851, 1994
26. Fellous K, Jian R, Haniche M, Marteau P, Messing B, Rain JD, Modigliani R: Mesure de l'absorption iléale des sels biliaires par le test à l'homotaurocholate marqué au sélénium 75. Validation et signification clinique. Gastroenterol Clin Biol 18:865-872, 1994
27. Sylwestrowicz TA, Shaffer A: Effect of bile acid therapy in patients with gallstones. Gastroenterology 95:740-748, 1988
28. van Erpecum KJ, van berge Henegouwen GP, Stolk MFJ, Hopman WPM, Jansen JBM, Lamers CBHW: Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 99:836-842, 1990
29. Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, Parini P, Orsini M, Primerano AMM, Mazzella G, Aldini R, Roda E: Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 99:1779-1785, 1990
30. Jazrawi RP, de Caestecker JS, Goggin PM, Britten AJ, Joseph AEA, Maxwell JD, Northfield TC: Kinetics of hepatic bile acid handling in cholestatic liver disease: Effect of ursodeoxycholic acid. Gastroenterology 106:134-142, 1994
31. Stiehl A: Bile salt sulphates in cholestasis. Eur J Clin Invest 4:59-63, 1974
32. Makino I, Hashimoto H, Shinozaki K, Yoshino K, Nakagawa S: Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases. Gastroenterology 68:545-553, 1975
33. Chretien Y, Poupon R, Gerhardt MF, Chazouilleres O, Labbe D, Myara A, Trivin F: Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: Effect of ursodesoxycholic treatment. Gut 30:1110-1115, 1989
34. Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, Roda A, Cipolla A, Polimeni C, Tonelli D, Roda E: Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig Dis Sci 38:896-902, 1993
35. Stiehl A, Raedsch R, Rudolph G: Acute effects of ursodeoxycholic acid and chenodeoxycholic acid on the small intestinal absorption of bile salts. Gastroenterology 98:424-428, 1990
36. Hofmann AF: Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol 29 (Suppl 204):1-15, 1994
37. Poupon R, Poupon RE: Médical treatment of primary biliary cirrhosis. In Cholestasis, P Gentilini et al. (eds). Amsterdam, Elsevier Science B.V., 1994, pp 247-252